Bartoli et al., “In vitro and in vivo antitumoral activity of free, and encapsulated taxol,” J. Microencapsulation 7:191-197, 1990. |
Jampel et al., “In vitro release of hydrophobic drugs from polyanhydride disks,” Ophthalmic Surgery 22(11):676-680, 1991. |
Grinstaff et al., “Intravenous Targeted Delivery of Taxol in Protein Microspheres,” Abstracts of Papers, American Chemical Society, 207th National Meeting 207(1-2): Abstract 91, Mar. 13-17, 1994. |
“Synthesis and biological activity of water soluble polymer-bound taxol derivates”, Abstract, Experimental Therapeutics, Proc. Amer. Assoc. Cancer Res. 36:307, 1995. |
Walter et al., “Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma,” Cancer Research 54:2207-2212, 1994. |
Cserhati and Hollo, “Interaction of taxol and other anticancer drugs with hydroxypropyl-β-cyclodextrin,” International Journal of Pharmaceutics 108:69-75, 1994. |
Dordunoo et al., “Taxol encapsulation in poly(β-caprolactone) microspheres,” Cancer Chemother. Pharmacol. 36:279-282, 1995. |
Burt et al., “Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid),” Cancer Letters 88:73-79, 1995. |
Smith et al., “Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts,” Anti-Cancer Drugs 6:717-726, 1995. |
Paul et al. “Matrix Metalloproteinase Inhibitors in the Treatment of Rheumatoid Arthritis and Cancer,” Abstracts of Papers American Chemical Society 205(1/2): MEDI 147, 1993. |
Notice of Opposition of Grant of European Patent 706376 by Biocompatibles Limited. Produced by Gill Jennings & Every. Dated Mar. 25, 1998. |
Further Letter Concerning Notice of Opposition of Grant of European Patent 706376 by Biocompatibles Limited. Produced by Gill Jennings & Every. Dated Mar. 25, 1998. |
Notice of Opposition of Grant of European Patent 706376 by Focal, Inc. Produced by Hoffmann Eitle. Dated Mar. 25, 1998. |
Notice of Opposition of Grant of European Patent 706376 by Schering AG. Produced by Frohwitter. Dated Mar. 25, 1998. |
Supplement to Notice of Opposition of Grant of European Patent 706376 by Schering AG. Produced by Frohwitter. Dated Mar. 25, 1998. |
Notice of Opposition of Grant of European Patent 706376 by Inflow Dynamics AG. Produced by Patentanwalt Uwe Czybilka. Dated Mar. 25, 1998 (English translation also provided). |
Notice of Opposition of Grant of European Patent 706376 by STS Biopolymers, Inc.. Produced by J.A. Kemp &Co.. Dated Mar. 25, 1998. |
Decision revoking European Patent EP-B-0706376, European Patent Office, Opposition Division, Jul. 11, 2000. |
Provisions of a copy of the minutes of the oral proceedings, European Patent EP-B-0706376, European Patent Office, Opposition Division, Jul. 11, 2000. |
Daniels et al., “Taxol treatment of experimental proliferative vitreoretinopathy,” Graefe's Arch. Clin. Exp. Ophthalmol. 228:513-516, 1990. |
Van Bockxmeer, et al., “Taxol fro the Treatment of Proliferative Vitreoretinopathy,” Investigative Ophthalmology & Visual Science 26(8):1140-1147, 1985. |
McGuire et al., “Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms,” Annals of Internal Medicine 111:273-279, 1989. |
Winternitz et al., “Development of a polymeric surgical paste formulation for taxol,” Pharmaceutical Research, 13(3):368-375, 1996. |
Joseph et al., “Taxol, cytochalasin B and colchicines effects on fibroblast migration and contraction: a role in glaucoma filtration surgery?” Current Eye Research 3(2):203-215, 1989. |
Jampel et al., “The effect of paclitaxel powder on glaucoma filtration surgery in rabbits,” Journal of Glaucoma 7:170-177, 1998. |
Blandford et al., “Subconjunctival Sustained Release 5-Fluorouracil,” Investigative Ophthalmology & Visual Science 33(12):3430-3434, 1992. |
Jampel, H.D., “Impact of adjuvant chemotherapy on glaucoma filtration surgery,” Journal of Glaucoma 2:58-63, 1993. |
Constable, I., “Biological and therapeutic aspects of proliferative vitreoretinopathy,” Jpn. J. Ophthalmol. 31:512-520, 1987. |
Denis et al., “A highly efficient, practical approach to natural taxol,” J. Am. Chem. Soc. 110:5917-5919, 1988. |
Verdoorn et al., “Cellular Migration, Proliferation, and Contraction: An in vitro Approach to a Clinical Problem—Proliferative Vitreoretinopathy,” Arch. Ophthalmol. 104:1216-1219, 1986. |
Koszka et al., “Developmental changes in phosphorylation of MAP-2 and Synapsin I in cytosol and taxol polymerized microtubules from chicken brain,” Neurochemical Research 16:637-644, 1991. |
Kumar, N., “Taxol-induced polymerization of purified tubulin,” Journal of Biological Chemistry 256(20):10435-10441, 1981. |
Hruban et al., “Taxol toxicity: epithelial necrosis in the Gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest,” Cancer 63:1944-1950, 1989. |
Parness and Horwitz, “Taxol binds to polymerized tubulin in vitro,” Journal of Cell Biology 91:479-487, 1981. |
Hamel et al., “Interactions of taxol, microtubule-associated proteins, and guanine nucleotides in tubulin polymerization,” Journal of Biological Chemistry 256(22):1187-11894, 1981. |
English Abstract of German Patent DE 3825374 A1, espacenet.com, Nov. 28, 2001. |
English Abstract of French Patent FR 2693193 A1, espacenet.com, Nov. 29, 2001. |
Ike et al., “Biodegradation and antitumor effect of adriamycin-containing poly(L-lactic acid) microspheres,” Biomaterials 12: 757-762, Oct. 1991. |
Sloboda et al., “Studies of the Effect of Mitoxantrone on Adjuvant Induced Arthritis in Rats,” Clinical Immunology and Immunopathology 40: 236-243, 1986. |